Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cryoport, Inc.CYRX · Entity 5125 | Chief Financial Officer | June 04, 2026 | June 09, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cryoport, Inc.
Report date June 04, 2026 · Filed June 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 109,850 |
Reported balance
After 2026-06-04 transaction · row 1
1 source rowRow 1 · 2026-06-04 · Sale · Disposed 169,427 · Balance 109,850 F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2026 Filed Jun 9, 2026 01:11 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 169,427 | $16.27 | $2,756,983.91 |
DisclosureSEC source: 0001104659-26-071509 · tm2617191-5_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,850 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.05 to $16.70, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 23, 2026 Filed Mar 26, 2026 00:01 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,094 | $8.18 | $8,948.92 |
DisclosureSEC source: 0001104659-26-034754 · tm269766-3_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 279,277 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 16, 2026 Filed Mar 17, 2026 01:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 2,743 | $8.00 | $21,944.00 |
DisclosureSEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 4 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,371 F4 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 01:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 82,240 | $0.00 Strike: $8.60 | $0.00 |
DisclosureSEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · derivative · entry 6 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,240 Underlying: Common Stock · 82,240 shares Expires 2033-03-14 F6 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2026. Read SEC document |
| March 14, 2026 Filed Mar 17, 2026 01:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 27,413 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 283,114 F3 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027. F3 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2027. Read SEC document |
| March 12, 2026 Filed Mar 17, 2026 01:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 87,188 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · derivative · entry 5 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 87,188 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 1/48 of options vested on the 6th of each month for forty-eight months beginning May 6, 2016. Read SEC document |
| March 12, 2026 Filed Mar 17, 2026 01:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 38,700 | $7.76 | $300,385.53 |
DisclosureSEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,701 F1 · kind: The proceeds of the sale of Common Stock were used to pay the exercise price and withholding taxes due upon exercise of the Stock Option reported in this Form 4. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.725 to $7.83, inclusive. Read SEC document |
| March 12, 2026 Filed Mar 17, 2026 01:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 87,188 | $1.87 | $163,041.56 |
DisclosureSEC source: 0001104659-26-028775 · tm269014-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 26,164 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-25-081460 · tm2524098-1_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,164 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 9,300 | $8.67 | $80,617.98 |
DisclosureSEC source: 0001104659-25-081460 · tm2524098-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,213 F1 · kind: The proceeds of the sale of Common Stock were used to pay the exercise price due upon the exercise of the Stock Option reported in this Form 4. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.60 to $8.75, inclusive. Read SEC document |
| August 19, 2025 Filed Aug 21, 2025 21:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 26,164 | $3.07 | $80,323.48 |
DisclosureSEC source: 0001104659-25-081460 · tm2524098-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,513 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,070 | $6.94 | $7,427.51 |
DisclosureSEC source: 0001104659-25-028322 · tm2510559-2_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 190,349 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 17, 2025 Filed Mar 18, 2025 23:07 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,659 | $6.29 | $10,437.93 |
DisclosureSEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,419 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:07 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2032-03-14 F3 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning April 14, 2025. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 23:07 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-025194 · tm259699-3_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 193,078 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 14, 2026. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,256 | $4.88 | $6,128.15 |
DisclosureSEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,078 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2025. Read SEC document |
| March 09, 2025 Filed Mar 11, 2025 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-022642 · tm258882-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,334 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 23:13 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 53,334 | $0.00 Strike: $4.80 | $0.00 |
DisclosureSEC source: 0001104659-24-128537 · tm2431099-1_4seq1.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,334 shares Expires 2024-12-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options vested ratably beginning on the 18th of each month for forty-eight months beginning on 1/18/2015. Read SEC document |
| December 11, 2024 Filed Dec 13, 2024 23:13 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 53,334 | $4.80 | $256,003.20 |
DisclosureSEC source: 0001104659-24-128537 · tm2431099-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 00:12 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,079 | $17.54 | $18,928.14 |
DisclosureSEC source: 0001104659-24-039195 · tm249900-3_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,333 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 11,500 | $0.00 Strike: $16.70 | $0.00 |
DisclosureSEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · derivative · entry 6 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 11,500 shares Expires 2031-03-15 F5 · derivative.exercise_date: 1/48 of options vest on the 15th of each month for forty-eight months beginning April 25, 2024. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 5,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 4 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 129,412 F3 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. F3 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning March 15, 2025. Read SEC document |
| March 15, 2024 Filed Mar 19, 2024 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,035 | $15.43 | $15,972.33 |
DisclosureSEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,662 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 11, 2024 Filed Mar 19, 2024 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,119 | $16.35 | $18,298.34 |
DisclosureSEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,697 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 09, 2024 Filed Mar 19, 2024 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 2,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · derivative · entry 5 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,667 Underlying: Common Stock · 2,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F4 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. F4 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning March 9, 2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2024. Read SEC document |
| March 09, 2024 Filed Mar 19, 2024 23:51 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-036286 · tm249281-5_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,816 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 21:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 16,000 | $0.00 Strike: $3.07 | $0.00 |
DisclosureSEC source: 0001104659-23-096929 · tm2325164-1_4.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,164 Underlying: Common Stock · 16,000 shares Expires 2025-08-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: 1/48 of the options vested on the 20th of each month for forty-eight months beginning on August 19, 2015. Read SEC document |
| August 29, 2023 Filed Aug 30, 2023 21:30 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 16,000 | $3.07 | $49,120.00 |
DisclosureSEC source: 0001104659-23-096929 · tm2325164-1_4.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,150 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: No Common Stock was sold by the reporting person in connection with the transactions disclosed on this Form 4. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 19,918 | $0.00 Strike: $3.24 | $0.00 |
DisclosureSEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,918 shares Expires 2023-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested over four years in 48 equal installments beginning 7/28/2013. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 19,918 | $21.94 | $437,022.83 |
DisclosureSEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,150 F1 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.575 to $22.27, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| May 10, 2023 Filed May 12, 2023 22:21 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 19,918 | $3.24 | $64,534.32 |
DisclosureSEC source: 0001104659-23-059931 · tm2315733-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 127,068 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 20,910 | $0.00 Strike: $23.78 | $0.00 |
DisclosureSEC source: 0001104659-23-036715 · tm2310574-3_4seq1.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,910 Underlying: Common Stock · 20,910 shares Expires 2030-03-22 F2 · derivative.exercise_date: 1/48 of options vest on the 22nd of each month for forty-eight months beginning 4/22/2023. Read SEC document |
| March 22, 2023 Filed Mar 24, 2023 22:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 10,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-036715 · tm2310574-3_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,150 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/22/2024. Read SEC document |
| March 15, 2023 Filed Mar 17, 2023 20:15 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,069 | $20.79 | $22,224.51 |
DisclosureSEC source: 0001104659-23-033868 · tm239899-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,695 F1 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 01:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,159 | $20.14 | $23,342.26 |
DisclosureSEC source: 0001104659-23-031941 · tm239488d3_4.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,764 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031941 · tm239488d3_4.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,333 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2023. Read SEC document |
| March 09, 2023 Filed Mar 14, 2023 01:25 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-031941 · tm239488d3_4.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,923 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantStock Option (right to buy) · Derivative | 20,910 | $0.00 Strike: $29.69 | $0.00 |
DisclosureSEC source: 0001104659-22-034627 · tm229493-2_4seq1.xml · derivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,910 Underlying: Common Stock · 20,910 shares Expires 2029-03-14 F2 · derivative.exercise_date: 1/48 of options vest on the 14th of each month for forty-eight months beginning 4/14/2022. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 23:00 UTC | Cryoport, Inc. CYRX · Entity 5125 | GrantCommon Stock | 10,455 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-034627 · tm229493-2_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,256 F1 · security: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023. F1 · price: Represents restricted stock rights, which are a contingent right to receive one share of CYRX common stock, that vest in four equal annual installments beginning 3/14/2023. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:50 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionRestricted Stock Rights · Derivative | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 2,667 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F3 · derivative.exercise_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. F3 · derivative.expiration_date: The originally granted restricted stock rights vest in four equal annual installments beginning 3/9/2022, and have no expiration date. The restricted stock rights reported herein vested and converted to shares of CYRX common stock on a one-for-one basis on March 9, 2022. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:50 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 1,095 | $31.05 | $33,999.75 |
DisclosureSEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,801 F2 · kind: Shares required to be sold in accordance with the Issuer's policies, in payment of taxes due upon the vesting of restricted stock rights. Read SEC document |
| March 09, 2022 Filed Mar 11, 2022 22:50 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 2,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-032999 · tm228984-3_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,896 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. F1 · price: Represents the conversion of restricted stock rights to shares of common stock upon vesting. Each restricted stock right represents a contingent right to receive one share of CYRX common stock. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 00:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 5,000 | $0.00 Strike: $5.16 | $0.00 |
DisclosureSEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · derivative · entry 4 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2022-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vested in equal installments every 6 months for 48 months. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 00:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 47,812 | $0.00 Strike: $1.87 | $0.00 |
DisclosureSEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · derivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,812 shares Expires 2026-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/48 of the options vested on the 6th of each month for forty-eight months beginning on May 6, 2016. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 00:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 5,000 | $5.16 | $25,800.00 |
DisclosureSEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 27, 2022 Filed Feb 1, 2022 00:35 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionCommon Stock | 47,812 | $1.87 | $89,408.44 |
DisclosureSEC source: 0001104659-22-009896 · tm225040-1_4seq1.xml · nonDerivative · entry 1 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,229 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | Exercise / conversionOptions to purchase common stock · Derivative | 49,918 | $0.00 Strike: $7.80 | $0.00 |
DisclosureSEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · derivative · entry 4 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,566 Underlying: Common Stock · 49,918 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F4 · derivative.exercise_date: Options vested on the 7th of each month for 48 months beginning on June 7, 2015. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 6,180 | $68.38 | $422,580.98 |
DisclosureSEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · nonDerivative · entry 3 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,417 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $68.18 to $68.79, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 14, 2021 Filed Oct 15, 2021 22:57 UTC | Cryoport, Inc. CYRX · Entity 5125 | SaleCommon Stock | 43,738 | $67.60 | $2,956,675.68 |
DisclosureSEC source: 0001104659-21-126858 · tm2130186-1_4seq1.xml · nonDerivative · entry 2 STEFANOVICH ROBERT · CIK 0001247309 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,597 F1 · kind: The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2021. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.17 to $68.15, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.